Analysis of Glioblastoma Multiforme Treatment Market Dynamics and Strategic Positioning of Key Players
The global Glioblastoma Multiforme (GBM) treatment market is poised for significant growth and is expected to reach a valuation of USD 4.82 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.9% during the forecast period. This upward trajectory is driven by rising incidences of brain tumors, increasing awareness about GBM, advancements in therapeutic technologies,...
0 Comentários
0 Compartilhamentos